A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride

Yükleniyor...
Küçük Resim

Tarih

2018

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Modestum Ltd.

Erişim Hakkı

Attribution 4.0 International (CC BY 4.0)
info:eu-repo/semantics/openAccess

Özet

Neuroleptic malignant syndrome is a severe complication that mainly occurs based on neuroleptic drug treatment and characterized with some autonomic symptoms, altered mental state, hyperthermia and muscle rigidity. Amisulpride is a unique atypical antipsychotic that selectively blocks D2 and D3 receptors presynaptically in the frontal cortex and atypical antipsychotics are rarely caused neuroleptic malignant syndrome (NMS). This study examine a 20-years old male with the diagnosis of acute psychotic disorder occurred amisulpride-induced NMS and successfully treated with Electroconvulsive Therapy (ECT). We decided to present that case because of the fact that there is only limited number of amisulpride-induced NMS cases reported in the literature. © 2018 by the authors; licensee Modestum Ltd., UK.

Açıklama

Anahtar Kelimeler

Amisulpride, Atypical Antipsychotics, Electroconvulsive Therapy, Neuroleptic Malignant Syndrome

Kaynak

Electronic Journal of General Medicine

WoS Q Değeri

N/A

Scopus Q Değeri

Q1

Cilt

15

Sayı

3

Künye

Karayağmurlu, A., Karayağmurlu, E., Üstündağ, M. F., Yazla, E. (2018). A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride. Electronic Journal of General Medicine, 15(3).